(Corrects paragraph 3 to show Roche is bidding to buy the remaining 44 pct in Genentech not 56 pct)
ZURICH, Jan 15 (Reuters) - Roche Holding AG ROG.VX confirmed its 2008 targets on Thursday, saying it still expected a high single-digit increase in local currency sales and above market sales growth in both drugs and diagnostics units.
In a presentation for investors, Roche also reiterated that it expects a continuous increase in dividend payout ratio over the next three years.
The Swiss drugmaker also confirmed its bid to buy the 44 percent of U.S. biotech company Genentech Inc DNA.N that it does not already own, saying it was a platform to realise certain synergies in the United States. (Reporting by Sam Cage; Editing by Mike Nesbit)